Yeji
NDA/BLA filedconf 0.70

NDA/BLA filed

$EDIT · Editas Medicine, Inc.
Event date
Date TBD
Sponsor runway
16 mo
$123.6M liquid

Evidence

“The Company also received pre-IND feedback from the U.S. Food and Drug Administration ("FDA") on its nonclinical package, CMC plans, and study design to support an Investigational New Drug Application ("IND") for EDIT-401”
Source: 8-K filed 2026-05-26View on EDGAR ↗0001104659-26-065908

Comparable historical nda/bla fileds· last 5 years · same event type

TickerDrugDateOutcome
$AXSM—2025-12-31unknown
$RCKTkresladi2025-10-14unknown
$ALDXreproxalap2025-07-17unknown
$ETONet-6002025-07-08unknown
$BCRXorladeyo (berotralstat)2025-05-14unknown
$CORTrelacorilant2025-03-03unknown
$ALDXreproxalap2024-11-01unknown
$AXSMaxs-072024-09-04unknown
$RCKTkresladi2023-10-02unknown
$GERNimetelstat2023-08-21unknown

Recent insider activity· ±90 days

No insider Form 4 activity reported on $EDIT in the 90 days around this event.
← All catalysts for $EDIT